Sign in with Google. Opens in new tab
bearish
Celltrion (068270 KS): Increasing Biosimilar Competition- Main Concerning Factor
335 Views08 Mar 2022 16:56
SUMMARY
- Fierce competition is an industry-wide phenomena in biosimilar products. Despite being an early mover, Celltrion Inc (068270 KS) is also facing competition for its marketed biosimilars.
- The market share of Celltrion’s key biosimilar product, Remsima is declining. Other marketed and upcoming biosimilars also have multiple existing players.
- With the waning COVID-19 infections in the U.S., demand for Celltrion’s rapid test kits seems uncertain.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Santos Ltd (STO AU): FIRB Approval For XRG's Tilt Will Be No Pushover
- Gold Miners ETF (GDX US): BIG Impact of Benchmark Change
- SET50 Index Rebalance: Four Changes in Two Weeks; DELTA Capping Too
- Nakano Refrigerators (6411 JP): Marunouchi Capital’s JPY7,900 Tender Offer
- Vishal Mega Mart (VMM IN) Placement: PE Selling Will Lead to Large Passive Buying
Top Unpaywalled Insights
More »- Overview #27 – The Big Beautiful Tragi-Comedy Continues
- HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
- [IO Technicals 2025/24] Downward Momentum Lingers
- China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
- Bearishness Persist in Soybeans Despite Rebound Hopes
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Celltrion Group Companies - Sharp Increase in Dividends16 Dec 2022
- Celltrion (068270 KS): Competition Makes US Approval of New Oncology Biosimilar Unappealing29 Sep 2022
- Celltrion (068270 KS): Muted Q1 2022 Performance Reflects Continuing Biosimilars Pricing Pressure14 May 2022
- Celltrion (068270 KS): Increasing Biosimilar Competition- Main Concerning Factor08 Mar 2022
- FSC Finally Reviews Accounting Fraud Allegations of Celltrion Group After 3 Years of Investigation23 Nov 2021
- Celltrion Inc - The Minority Shareholders Upheaval & Concerns About Potential Inheritance Tax Issue14 Oct 2021
x